paediatrics Brussels 17

Previous Page

Next Page

Page Background

Standard-Risk Medulloblastoma

Study

Treatment

Chemotherapy 5-year

EFS

5-year OS

SJMB96

(Gajjar)

23.4 Gy CSI, 36 Gy PF, 55.8 Gy/31 fx

TB

Yes

83% 85%

Packer

(CCG

A9961)

23.4 Gy CSI, 55.8 Gy PF

Yes

81% 86%

Lannering

(HIT SIOP

PNET 4)

23.4 Gy CSI, PF 55.8 Gy

Yes

77% 87%